What steps is SAMHSA taking to combat the possible diversion of buprenorphine?
Larry Bucshon: “What steps is SAMHSA taking to combat the possible diversion of buprenorphine?”
Editor's note · Context
Bucshon questions SAMHSA about measures against buprenorphine diversion.
Share
More from Larry Bucshon
I thank Chairman Bilirakis for those kind remarks. Mr. Speaker, I rise in support of Dr. Miller-Meeks' bill, the Critical Infrastructure Manufacturing Feasibility Act, which I am proud to co-lead. Indiana is an extremely…
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House suspend the rules and…
Again, we need to implement the HALT Fentanyl Act now. Any further delay, including the Biden administration slow- walking its implementation, is unacceptable. I again urge a ``no'' vote on this amendment, and I yield back the balance of…
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House suspend the rules and…





